It’s very interesting to show that, at HCS Pharma, we work on many of the most exciting medical technologies identified by Dr. Bertalan Mesko on his blog, medicalfuturist.com. Of course, precision medicine is the most important for us, because we see here extraordinary tools to treat cancer and neurodegenerative diseases (“instead of canons, we start using sniper rifles.”)

But two other fields seem really promising. The 3D bioprinting for exemple will give us the possibility to create relevant in vitro models of living tissues. We also work to integrate IA deep learning in our HCS processes. It will be a major method to find phenotypic actions of futur drugs.

2016 was a rich year for medical technology. Virtual Reality. Augmented Reality. Smart algorithms analysing wearable data. Amazing technologies arrived in our lives and on the market almost every day. And it will not stop in the coming year.

Source: The Most Exciting Medical Technologies of 2017 – The Medical Futurist


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

Leave a Reply